Mural Oncology (MURA)
NASDAQ: MURA
· Real-Time Price · USD
1.77
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.79
1.13%
After-hours: Aug 15, 2025, 05:02 PM EDT
Mural Oncology Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Revenue | n/a | n/a | 3.49M | n/a | n/a | n/a | 2.62M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 868K | n/a | 900K | 846K | 613K | 779K | n/a | 530K | 497K | 372K |
Gross Profit | n/a | n/a | 1.75M | n/a | -900K | -846K | 2M | -779K | n/a | -530K | -497K | -372K |
Operating Income | -31.36M | -34.38M | -35.85M | -34.1M | -34.28M | -34.03M | -58.51M | -46.31M | -49.4M | -44.16M | -57.59M | -49.3M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -47.98M | -33.14M | -34.27M | -31.76M | -31.56M | -30.92M | -57.56M | -46.31M | -49.4M | -44.16M | -57.59M | -49.3M |
Net Income | -47.98M | -33.14M | -34.27M | -31.76M | -31.56M | -30.92M | -59.54M | -51.28M | -52.31M | -46.47M | -58.8M | -50.64M |
Selling & General & Admin | 8.08M | 6.96M | 7.73M | 6.51M | 6.73M | 6.62M | 16.27M | 5.96M | 6.7M | 3.62M | 12.31M | 4.53M |
Research & Development | 23.28M | 27.43M | 29.37M | 27.59M | 27.14M | 26.57M | 42.24M | 40.35M | 42.7M | 40.01M | 45.27M | 44.77M |
Other Expenses | 17.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 48.84M | 34.38M | 34.99M | 34.1M | 34.28M | 33.19M | 58.51M | 46.31M | 49.4M | 43.63M | 57.59M | 49.3M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -546K | n/a | n/a | n/a | -130K | n/a | n/a |
Cost & Expenses | n/a | 34.38M | 35.85M | 34.1M | 34.28M | 34.03M | 58.51M | 46.31M | 49.4M | 44.16M | 57.59M | 49.3M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.98M | 4.97M | 2.91M | 2.31M | 1.22M | 1.34M |
Shares Outstanding (Basic) | 17.27M | 17.17M | 17.07M | 17.03M | 16.92M | 16.79M | 16.69M | 16.69M | 16.69M | 16.69M | 16.69M | 16.69M |
Shares Outstanding (Diluted) | 17.27M | 17.17M | 17.07M | 17.03M | 16.92M | 16.79M | 16.69M | 16.69M | 16.69M | 16.69M | 16.69M | 16.69M |
EPS (Basic) | -2.78 | -1.93 | -2.01 | -1.87 | -1.86 | -1.84 | -3.57 | -3.07 | -3.13 | -2.78 | -3.52 | -3.03 |
EPS (Diluted) | -2.78 | -1.93 | -2.01 | -1.87 | -1.86 | -1.84 | -3.57 | -3.07 | -3.13 | -2.78 | -3.52 | -3.03 |
EBITDA | n/a | -33.53M | -34.99M | -33.2M | -33.38M | -33.19M | -56.95M | -45.53M | -46.61M | -43.63M | -57.09M | -48.93M |
EBIT | n/a | -34.38M | -35.85M | -34.1M | -31.56M | -34.03M | -58.51M | -46.31M | -47.26M | -44.16M | -57.59M | -49.3M |
Depreciation & Amortization | n/a | 851K | 868K | 899K | 900K | 846K | 613K | 779K | 645K | 530K | 497K | 372K |